InflaRx (IFRX) Operating Income (2018 - 2026)

InflaRx's Operating Income history spans 7 years, with the latest figure at -$8.4 million for Q1 2026.

  • On a quarterly basis, Operating Income rose 38.31% to -$8.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.1 million, a 870.36% increase, with the full-year FY2025 number at -$56.18, up 0.83% from a year prior.
  • Operating Income hit -$8.4 million in Q1 2026 for InflaRx, down from $41.2 million in the prior quarter.
  • Over the last five years, Operating Income for IFRX hit a ceiling of $46.2 million in Q4 2024 and a floor of -$16.9 million in Q3 2024.
  • Historically, Operating Income has averaged -$4.1 million across 5 years, with a median of -$11.1 million in 2025.
  • Biggest five-year swings in Operating Income: plummeted 140083597.94% in 2023 and later soared 422.78% in 2024.
  • Tracing IFRX's Operating Income over 5 years: stood at -$7.9 million in 2022, then plummeted by 82.27% to -$14.3 million in 2023, then skyrocketed by 422.78% to $46.2 million in 2024, then dropped by 10.83% to $41.2 million in 2025, then tumbled by 120.48% to -$8.4 million in 2026.
  • Business Quant data shows Operating Income for IFRX at -$8.4 million in Q1 2026, $41.2 million in Q4 2025, and -$11.1 million in Q3 2025.